We tested the hypothesis that a force reduction in hyperthyroid rat soleus muscle would be associated with oxidative modification in myosin heavy chain (MHC). Daily injection of thyroid hormone (3,5,3'-triiodo-L -thyronine, T 3 ) for 21 days depressed isometric forces of whole soleus muscle across a range of stimulus frequencies (P < 0.01). In fiber bundles, hyperthyroidism also led to pronounced reductions (P < 0.01) in both K + -and 4-chloro-m-cresol-induced contracture forces. The degrees of the reductions were similar between these two contractures that were induced by distinct reagents. Treatment with T 3 elicited a significant decrease (ዊ14%; P < 0.05) in the relative content of MHC contained in myofibrillar proteins. The content of carbonyl groups in myofibrillar protein extracts was elevated (P < 0.05) by ዊ50% in T 3 -treated muscles. Immunoblot analyses on T 3 -treated muscles showed a greater increase (106%; P < 0.05) of the carbonyl content in MHC than in myofibrillar protein extracts. These data suggest that in hyperthyroidism, the decrease in force production of skeletal muscles may stem primarily from failure in myofibrillar protein function resulting from oxidative modification of MHC.
Introduction
Despite the well-accepted view that loss of muscle strength and exercise intolerance are prominent clinical features of hyperthyroid patients (33) , the mechanisms underlying the depressed capacity of contractile function in skeletal muscle remain incompletely understood. Although protein degradation due to accelerated proteolysis has been found in skeletal muscle of patients with hyperthyroidism (2, 38) , it seems unlikely that the protein loss contributes only to the muscle weakness in hyperthyroid skeletal muscles. Based mainly on clinical examinations, muscle strength has been shown to decrease by 40-100%, whereas muscle mass only reduced by approximately 20% in hyperthyroidism (29, 46) , suggesting that the observed reduction in force may result not only from muscle atrophy, but also from the failures in the excitation-contraction (EC) coupling process.
In contrast to clinical observations, the effects of thyroid hormone on isometric properties in the animal model are controversial. A hyperthyroid state has been reported to consistently decrease the isometric twitch force (12, 13, 26, 44) , but to either decrease (44) or maintain the maximum tetanic force at control levels (12, 13, 26) . This discordance seems likely to be related to the dosage of thyroid hormone administered to the animals. For example, Merican and coworkers (26, 44) have studied the effects of two doses of thyroxine treatment on the isometric properties of cat soleus muscles; 25 µg kg -1 every 3rd day and 250 µg kg -1 3 times week -1 for 10 weeks. The significant decrease in maximum tetanic force was observed only in higher dose (44) . Consistent with these experiments, we previously confirmed that the higher dosage (300 µg kg -1 4 day -1 ) of 3,5,3'-triiodo-L -thyronine (T 3 ) treatment induced the significant depression in maximum tetanic force in rat soleus muscles (43) .
Protein oxidation could play an important role in an etiology of contractile dysfunctions in hyperthyroidism because oxidative stress, as mediated by vigorous contractile activity, can modify the structure and function of proteins associated with EC coupling (28, 36) and since in hyperthyroid muscles, a hypermetabolic state that occurs with accelerated oxidative metabolism in the mitochondria brings about augmented production of reactive oxygen species (ROS) (3, 4, 11, 40) . Sarcoplasmic reticulum (SR) regulates intracellular free Ca 2+ concentration and plays a central role in the EC coupling process. Recent observations have implicated the impaired SR function as a major contributor to a depression in force induced by exercise to exhaustion (19) . There is substantial evidence to indicate that protein oxidation may account at least in part for the decay in SR function (24, 25) . However, the possibility seems remote that dysfunction of the SR may be a major factor for the hyperthyroid-induced decline in contractile function, because in a previous study from our laboratory, it was shown in rat soleus muscles that hyperthyroidism resulted in elevations in SR Ca 2+ release and uptake rates (42) .
The molecular basis for contractile ability of muscle fiber is the conversion of chemical energy to mechanical work by the cycling attachment and detachment of myosin motor protein with the actin filament. Although the functional behavior of myofibrillar proteins is deleteriously affected by intracellular accumulation of ROS, their susceptibilities to oxidative damage vary among different proteins (17) . On the 5 basis of its primary structure, myosin heavy chain (MHC), an asymmetrical molecule with distinct head and tail domains, has been argued to be highly susceptible to oxidation (17, 45) . MHC comprises sulfhydryl (SH)-containing cysteine residues critical for contractile function (23) . Single fiber study has revealed that ROS donorinduced oxidation of SH groups residing in the myosin head decreases isometric force production, maximal shortening velocity and ATPase activity (31) . Because SH groups are not involved in the catalytic activity of myosin ATPase, it is suggested that oxidation may result in a structure perturbation in myosin, leading to impaired myosin function. 
Methods

Animal care and treatment
Nine-week-old male Wistar rats at the beginning of the experiment were randomly assigned to an euthyroid (n = 9) and a hyperthyroid (n = 9) group. Animals assigned to the hyperthyroid group received daily intraperitoneal injections of T 3 (300 µg kg -1 day -1 ) for 21 days. Animals were given food and water ad libitum and housed in an environmentally controlled room (temperature, 22-25ºC) with a 12-h light-dark cycle. At the end of a given period, rats were sedated with pentobarbital sodium (50 mg kg -1 ) and the soleus muscles were excised from both legs. The experiment protocol was approved by Animal Care Committee of Hiroshima University.
Measurement of isometric contractile force
The muscles were dissected into small bundles, weighing ~30 mg. Isometric contractions of the bundles were recorded in a chamber, which had a volume of 200 ml and was filled with continuously stirred a temperature-controlled standard solution produced at 1-min intervals. Peak force in each contraction was measured and was normalized to cross-sectional area, where cross-sectional area was computed as muscle wet weight dividing by the product of muscle length and density (1.06 g ml -1 ).
Measurement of K + -and 4-CmC-induced contracture
The bundles were connected to an isometric force transducer in temperaturecontrolled chamber (30 o C) containing a standard solution and set at optimal length.
After 10 min of incubation, K + contracture was evoked by a standard solution in which the NaCl was replaced with 100 mM K 2 SO 4 . The bundles were rested for 5 min in a standard solution and then placed in a standard solution containing 10 mM 4-CmC to elicit 4-CmC contracture. This concentration was chosen as previous study indicated that the concentration of 4-CmC greater than 7.5 mM caused maximal contracture force (20) . The data were recorded throughout the period of experiments and peak tensions in both contractures were measured. Specific tension was calculated as described above. 
Glutathione contents
The amounts of total, reduced (GSH) and oxidized (GSSG) glutathione were determined by spectrophotometry methods, as described by Baker et al. (5 EDTA, 1 U ml -1 glutathione reductase, 0.1 mM NADPH (pH 7.5). After the addition of an aliquot of the sample, the assay mixture was incubated for 2 min. The reaction was started by adding 5, 5'-dithiobis-(2-nitrobenzoic acid) to give a final concentration of 0.4 mM. The glutathione concentration was determined spectrophotometrically at a wavelength of 412 nm. The GSH content was calculated as the difference between total glutathione and GSSG contents.
Myofibrillar protein extraction
Myofibrillar protein concentrations were measured according to Tsika et al. (39) .
Approximately 60 mg of muscle were homogenized in 10 volumes of a solution containing (in mM) 250 sucrose, 100 KCl, 20 imidazole, and 5 EDTA (pH 6.8). The homogenate was centrifuged at 3,000 g for 10 min, and the supernatant was discarded.
The resulting pellet was rehomogenized in 10 volumes of 175 mM KCl containing 0.5%
(vol vol -1 ) Triton X-100 (pH 6.8) and processed through two additional washes. After these washes, the pellet was subjected to two more washes in a solution of 150 mM KCl and 20 mM imidazole (pH 7.0). The resulting pellet was then homogenized in the same buffer and protein concentration was determined according to Bradford (6) , using bovine serum albumin as a standard. Just before use, all solutions used were stirred under vacuum to reduce the oxygen tension. Aliquots of myofibril extracts were used for measures of the carbonyl group content in myofibril and MHC. 
Myosin heavy chain content in myofibrillar proteins
Carbonyl content in total myofibrillar proteins
The carbonyl content in total myofibrillar proteins was determined by spectrophotometry methods, as described by Levine et al. 
Statistical analyses
A two-way variance analysis was performed to evaluate the influence of T 3 and duration of T 3 treatment. If an overall F-value was obtained, a Scheffé's post hoc analysis was used to isolate the significantly different means. All comparisons were performed at the 95% confidence level. The data were presented as means ± SE.
Results
Body, heart and muscle weights
Animals subjected to T 3 treatment maintained an approximately 2.8-fold increase in serum free T 3 levels 24 hours postinjection compared with controls (result not shown). This elevation was higher than that observed in previous studies (15, 30) using the lower dosage, but less than that of hyperthyroid human patients (38) .
The body and absolute soleus muscle weights from T 3 -treated animals were significantly lower than those of euthyroid group (Table 1) . T 3 treatment, however, caused no change in the normalized (the muscle-to-body weight ratio) soleus muscle weights. In contrast, T 3 -injection elicited significant increases in the absolute and normalized heart weights, suggesting that this protocol was effective in inducing a hyperthyroid state.
Isometric contractile force
Similar to what previous studies showed (12, 26, 27, 44) , twitch force developed by soleus muscles treated with T 3 was less (P < 0.01) than that of controls (414.0 ± 38.7 vs 618.9 ± 19.2 g/cm 2 ; Fig. 1 ). Hyperthyroidism also led to significant reductions (P < 0.01) in maximum tetanic force (2257.9 ± 123.0 vs 3093.5 ± 44.7 g/cm 2 ). Examined more broadly, T 3 treatment depressed force across the entire range of soleus muscle activation (P < 0.01). The force reduction in hyperthyroid group was more prominence at low stimulation frequency at which the tetanic contractions appeared unfused. (Fig. 2) . 4-CmC contracture force was also decreased by 39% (P < 0.01) in T 3 -treated muscles. No differences in the magnitude of the T 3 -induced depressions were observed between K + -and 4-CmC-induced forces.
Na
+ -K + -ATPase activity
The observed decline in K + -induced contracture force could be explained by the depressed sarcolemmal excitability. To investigate this possibility, Na + -K + -ATPase activity was measured in muscle homogenates. In contrast to our results of force, the activity, as assessed by 3-O-MFPase, was significantly (P < 0.05) increased by 41% in hyperthyroid group (Table. 2).
Myosin heavy chain content in myofibrillar proteins
The concentration of myofibrillar proteins contained in muscle was not different between hyperthyroid and euthyroid rats (results not shown). T 3 treatment resulted in significant reductions (P < 0.05) in the relative concentration of MHC in total myofibrillar proteins (Fig. 3b) . The MHC content in T 3 -treated muscles amounted to 86% of the euthyroid level. (Table 2 ). Fig. 4b shows the representative Western blots illustrating the carbonyl content in MHC. The densitometric evaluation of the blot revealed that treatment with T 3 evoked a 106% increase (P < 0.05) in the carbonyl content compared with euthyroid group (Fig. 4c) .
Carbonyl group and glutathione contents
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Discussion
The present study is the first to indicate that the force deficit in hyperthyroid rat soleus muscle would stem primarily from a failure in the EC coupling process at the level of myofibrillar proteins (see below). The reduction in force production was accompanied by a remarkable increment in DNPH-reactive carbonyls in MHC,
suggesting that oxidative modification of MHC may be responsible, at least in part, for an inability of cross-bridges to generate force in hyperthyroidism.
Level of EC coupling failure in hyperthyroid soleus muscle
Our results of the marked depressions in isometric forces, even when tensions were normalized by cross-sectional area, indicate that EC-coupling impairment may be responsible for hyperthyroid-induced contractile dysfunctions. The fact that the magnitude of T 3 -induced depressions showed no significant differences between peak twitch force and K + contracture force suggests that a failure in the EC coupling process occurs at or below the level of the voltage sensor, given that K + contractures are evoked by depolarizing transverse (t)-tubular membranes adjacent to the voltage sensors (10) and that no reductions were observed in Na + -K + -ATPase activity (Table. 2).
One of the important results in this study is that in T 3 -treated muscles, reductions in 4-CmC-induced force approximately correspond to those in K + -induced force. 4-CmC is a reagent specific for the CRC and activates the CRC directly and maximally.
Although it is obvious that decreases in CRC function attenuate the 4-CmC-induced contracture force, our previous study has shown no reductions in 4-CmC-induced SR 16 Ca 2+ release rate in T 3 -treated rat soleus muscle (42) . Accordingly, it is most likely that exposure of both euthyroid and hyperthyroid muscle fibers to 4-CmC would result in pronounced increases in myoplasmic free Ca 2+ concentration at which myofibrillar proteins are fully activated. Taken together, proportionate reductions between two contracture forces induced by distinct reagents imply that dysfunction of myofibrillar proteins may account primarily for T 3 -induced force depressions.
T 3 -induced oxidative stress
The ROS generation has been reported to increase in muscles after exercise and after reperfusion following ischemia (22, 34) . These highly reactive molecules are generated at several sites within muscle fiber and can cause cell and tissue injury by interacting with proteins and/or unsaturated bonds of lipid membranes. These detrimental effects are indicative of an oxidative stress. The stimulatory effect of T 3 on metabolism of all tissues is the best known action of this hormone. Previous studies, using biochemical markers for the cellular redox state, revealed that the hypermetabolic state due to hyperthyroidism would expose soleus muscles to oxidative stress (4). Our results of the decreased content of GSH, the most abundant nonprotein thiol source, agree with these findings and suggest that acceleration of ROS production induced in hyperthyroid soleus muscle would overwhelm biological antioxidant defense systems.
Susceptibility of MHC to ROS-induced damage
Skeletal muscle proteins have differential susceptibilities to ROS-induced oxidation (17, 18) . The susceptibility of lipids to ROS-mediated peroxidation has been described previously (36) . The t-tuble, SR, plasma membrane and mitochondria comprise the relatively large amounts of lipid. Of these, the inner membrane of mitochondrial is reported to be the most susceptible region (18) . Numerous studies have identified cysteine as the likely target of ROS other than lipids (36) . Although the reason is unknown, MHC containing cysteine residues critical for contractile function has been shown to exhibit a high susceptibility to ROS-induced modification (23) . For example, Zergeroglu et al. (45) studied the effects of mechanical ventilation, which evokes oxidative modification, on entire proteins in diaphragm and found severer oxidation in MHC than in others.
Reductions in MHC content
It has widely been accepted that introduction of carbonyl groups into amino acid residues of protein (carbonylation) can be a hallmark for oxidative modification (37) .
The results obtained in this study clearly point out that oxidation of MHC and the reduced content of MHC are brought about by hyperthyroidism. The precise mechanism for the decay in protein is unclear. However, it is conceivable that protein degradation due to the carbonyl formation may be responsible, at least partly, for the decreased MHC content, given that carbonylation is characterized by an irreversible modification which requires the proteolytic removal followed by the resynthesis of the affected protein (9) .
Whereas the maximum velocity of shortening is highly correlated with the rate of 18 cross-bridge dissociation, isometric peak tension is purported to be determined primarily by the number of cross-bridges and the force per cross bridge (14) . The decreased MHC content makes it likely that the observed reduction in 4-CmC-induced force might be ascribed to the decreased number of attached cross-bridge. It is unlikely, however, that this is the only mechanism because a 14% depression in the MHC content found in T 3 -treated muscle is too small to explain a 39% attenuation in 4-CmC-induced force ( Figs. 2 and 3 ).
Acute effects of MHC oxidation on contractile function
There is evidence to suggest that oxidation would induce not only quantitative, but also qualitative alterations in MHC proteins, leading to a decrease in force generation. For instance, acute exposure to mM levels of H 2 O 2 has been shown to reduce the maximal Ca
2+
-activated force of both fast-and slow-twitch fibers (32) . It is suggested that the deleterious influence of ROS on myosin function may be mediated through critical SH groups located on MHC, as loss of free SH groups in myosin decreases the population of myosin heads in the strong-binding structural state (23) .
This suggestion is reinforced by very recent study indicating, in the soleus muscle from heart failure rat, the organs of which undergo oxidative stress, that administration of antioxidant is capable of preventing carbonylation in myofibrillar proteins and improving force production (8) . On the basis of these previous findings and the results in this study, we propose that T 3 -mediated depressions in force production may be attributable to enhanced MHC oxidation which not only triggers protein degradation, but results in dysfunction of cross-bridge kinetics.
Perspective
This study advances our understanding of the mechanism by which the elevated level of thyroid hormone depresses contractile function in skeletal muscle. Our results implicate that the hyperthyroidism-induced loss of muscle strength and exercise intolerance may be ascribed to oxidative modification of MHC. In accordance with the results on rat, enhanced myofibrillar protein degradation also appears to occur in hyperthyroid human patients (1) . Clinical examination has shown that even after the circulating levels of thyroid hormone are normalized with medical treatment, impairment of muscle function occasionally lasts for prolonged periods (29) . From the present results, it would be expected that the protection of organs against oxidationinduced damage may prevent or inhibit decreases in tension developed by human skeletal muscles. Studies, using excised muscles in vitro or intact muscle in situ, have suggested that treatment with antioxidants is capable to offsetting the effects of ROS (35) . However, it was difficult to demonstrate this positive influence in humans.
Supplementation of antioxidant nutrients such as vitamin C, vitamin E and -carotene has been evaluated as ineffective aids (7). In further study, it would appear productive to examine antioxidant interventions available for use in humans. Values are means ± SE. n, number of samples; BWt, body weight; HWt, Heart weight; SWt, soleus muscle weight. * P < 0.01, compared with euthyroid group. 
